Inventor · disambiguated record
James P. Rizzi
Also filed as: RIZZI JAMES · RIZZI JAMES P · RIZZI JAMES PATRICK
44 granted patents·8 pending applications·2,233 citations·filing 1982–2022
98Inventor score
Top patents by PatentIndex Score
52 records- 0198US5863949AArylsulfonylamino hydroxamic acid derivativesPFIZER·Filed 1995·Granted Jan 26, 1999·528 cites·13 claims
- 0298US5861510AArylsulfonyl hydroxamic acid derivatives as MMP and TNF inhibitorsPFIZER·Filed 1995·Granted Jan 19, 1999·536 cites·11 claims
- 0396US7799782B2P38 inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2009·Granted Sep 21, 2010·600 cites·23 claims
- 0495US5223522AThiazolidinedione hypoglycemic agentsPFIZER·Filed 1992·Granted Jun 29, 1993·77 cites·6 claims
- 0593USRE49948EAryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2022·Granted Apr 30, 2024·1 cites·25 claims
- 0693US10144711B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2017·Granted Dec 4, 2018·8 cites·20 claims
- 0793US9908845B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2014·Granted Mar 6, 2018·16 cites·28 claims
- 0893US9896418B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2017·Granted Feb 20, 2018·9 cites·20 claims
- 0993US5120754AThiazolidinedione hypoglycemic agentsPFIZER·Filed 1991·Granted Jun 9, 1992·55 cites·22 claims
- 1092US11591355B2CD73 inhibitors and uses thereofPELOTON THERAPEUTICS INC·Filed 2021·Granted Feb 28, 2023·2 cites·25 claims
- 1192US9969689B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2017·Granted May 15, 2018·8 cites·20 claims
- 1291US6362216B1Compounds which inhibit tryptase activityARRAY BIOPHARMA INC·Filed 2000·Granted Mar 26, 2002·29 cites·12 claims
- 1391US5061717AThiazolidinedione hypoglycemic agentsPFIZER·Filed 1988·Granted Oct 29, 1991·59 cites·13 claims
- 1490US6440973B1Aryl and heteroaryl substituted fused pyrrole antiinflammatory agentsAMGEN INC·Filed 2000·Granted Aug 27, 2002·36 cites·30 claims
- 1589US10597366B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2018·Granted Mar 24, 2020·4 cites·18 claims
- 1689US7135575B2P38 inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2003·Granted Nov 14, 2006·29 cites·16 claims
- 1789US6605634B2Aryl and heteroaryl substituted fused pyrrole anti-inflammatory agentsAMGEN INC·Filed 2002·Granted Aug 12, 2003·33 cites·35 claims
- 1886US9884843B2Cyclic sulfone and sulfoximine analogs and uses thereofPELOTON THERAPEUTICS INC·Filed 2014·Granted Feb 6, 2018·9 cites·28 claims
- 1985US7521447B2P38 inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2004·Granted Apr 21, 2009·28 cites·33 claims
- 2083US8044083B2Kinase inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2007·Granted Oct 25, 2011·5 cites·12 claims
- 2183US6180643B1Aryl and heteroaryl substituted fused pyrrole antiinflammatory agentsAMGEN INC·Filed 1997·Granted Jan 30, 2001·49 cites·38 claims
- 2281US10807948B2Aromatic compounds and uses thereofPELOTON THERAPEUTICS INC·Filed 2016·Granted Oct 20, 2020·2 cites·18 claims
- 2379US8039639B2Kinase inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2011·Granted Oct 18, 2011·4 cites·1 claims
- 2477US8138181B2Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitorsALLEN SHELLEY·Filed 2008·Granted Mar 20, 2012·3 cites·29 claims
- 2575US9174981B2Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitorsBOYS MARK LAURENCE·Filed 2011·Granted Nov 3, 2015·3 cites·30 claims
- 2674US8026233B2P38 inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2007·Granted Sep 27, 2011·2 cites·19 claims
- 2773US8017641B2P38 inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2009·Granted Sep 13, 2011·1 cites·10 claims
- 2872US9809590B2Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2015·Granted Nov 7, 2017·1 cites·29 claims
- 2972US4914207AArylthiazolylimidazolesPFIZER·Filed 1989·Granted Apr 3, 1990·16 cites·11 claims
- 3072US2020190031A1Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3171US8518983B2P38 inhibitors and methods of use thereofMUNSON MARK·Filed 2009·Granted Aug 27, 2013·2 cites·8 claims
- 3268US6077864ACyclic sulfone derivativesPFIZER·Filed 1997·Granted Jun 20, 2000·27 cites·8 claims
- 3367US10669269B2Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Jun 2, 2020·0 cites·16 claims
- 3467US6380219B1Arylsulfonylamino hydroxamic acid derivativesPFIZER·Filed 2000·Granted Apr 30, 2002·2 cites·7 claims
- 3563US5994351AArylsulfonylamino hydroxamic acid derivativesPFIZER·Filed 1998·Granted Nov 30, 1999·15 cites·11 claims
- 3662US8841455B2Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as cFMS inhibitorsBOYS MARK LAURENCE·Filed 2010·Granted Sep 23, 2014·1 cites·41 claims
- 3761US5883131ACyclic sulfone derivativesPFIZER·Filed 1997·Granted Mar 16, 1999·8 cites·11 claims
- 3860US2019015377A1Compositions for Use in Treating Pulmonary Arterial HypertensionPELOTON THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3960US2024294548A1Tricyclic sultams and sulfamides as antitumor agentsPELOTON THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4058US4767743APeptide immunostimulantsPFIZER·Filed 1986·Granted Aug 30, 1988·8 cites·31 claims
- 4156US2020115404A1Cd73 inhibitors and uses thereofPELOTON THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4255US6509337B1Arylsulfonyl Hydroxamic Acid derivatives as MMP and TNF inhibitorsPFIZER·Filed 1998·Granted Jan 21, 2003·6 cites·8 claims
- 4355US2004180896A1P38 inhibitors and methods of use thereofFiled 2003·Application pending·0 cites
- 4451US6221914B1Sulfonamide bridging compounds that inhibit tryptase activityARRAY BIOPHARMA INC·Filed 1998·Granted Apr 24, 2001·4 cites·47 claims
- 4548US2010144751A1IMIDAZO[1,2-a]PYRIDINE COMPOUNDS AS RECEPTOR TYROSINE KINASE INHIBITORSARRAY BIOPHARMA INC·Filed 2008·Application pending·0 cites
- 4646US2006264431A1P38 inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2006·Application pending·0 cites
- 4745US4963689AHeterocyclicguanidines as 5HT3 antagonistsPFIZER·Filed 1989·Granted Oct 16, 1990·3 cites·9 claims
- 4845US2010234378A1Alkylsulfonamide-substituted triazoles as matrix metalloprotease inhibitorsARRAY BIOPHARMA INC·Filed 2007·Application pending·0 cites
- 4942US4452806ATreating diabetic complications with 5-(substituted phenyl)hydantoinsPFIZER·Filed 1982·Granted Jun 5, 1984·2 cites·20 claims
- 5040US12331068B2Compositions and methods for inhibiting CD73PELOTON THERAPEUTICS INC·Filed 2019·Granted Jun 17, 2025·0 cites·20 claims
Showing the top 50 of 52 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when James P. Rizzi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →